Trial SWOG-S0931


EVEREST: Everolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study.

Type: Treatment
Phase: Phase III
Status: Closed to Accrual with Ongoing Follow-up
Treatments: Anti-Angiogenesis
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Sarmad Sadeghi, M.D.
Other Trial Staff:  Cheryl Kefauver, Coordinator, Victoria Banerjee, Coordinator, Lagrimas Ilagan, D.M., Honorina Enright, D.M., Elysse Faye Ballon, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.